Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Annales D'Endocrinologie|June 19, 2012
Risk factors of mild cognitive impairment in middle aged patients with type 2 diabetes: a cross-section studyRui-Hua Chen, Xiao-Zhen Jiang, Xiao-Hui Zhao, et al.
BMC Gastroenterology|August 14, 2013
High expression level and nuclear localization of Sam68 are associated with progression and poor prognosis in colorectal cancerWen-Ting Liao, Jun-Ling Liu, Zheng-Gen Wang, et al.
BMC Gastroenterology|January 3, 2024
The important role of whole-process computed tomography guidance for percutaneous gastrostomy in esophageal cancer patients who are unsuitable for or have had unsuccessful attempts with endoscopic and fluoroscopic gastrostomyXiang Geng, Qing Zhao, Hang Yuan, et al.
Biosensors & Bioelectronics|January 25, 2022
"Hepatitis virus indicator"----the simultaneous detection of hepatitis B and hepatitis C viruses based on the automatic particle enumerationRu Cheng, Fu Zhu, Min Huang, et al.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae|November 9, 2019
[Psychometric Evaluation of the Union Physio-Psycho-Social Assessment Questionnaire]Yan Ping Duan, Jing Wei, Xia Hong, et al.
Frontiers in Oncology|October 17, 2022
Transarterial chemoembolization combined with apatinib with or without PD-1 inhibitors in BCLC stage C hepatocellular carcinoma: A multicenter retrospective studyWei-Li Xia, Xiao-Hui Zhao, Yuan- Guo, et al.
Cancer Letters|April 2, 2015
AC1MMYR2 impairs high dose paclitaxel-induced tumor metastasis by targeting miR-21/CDK5 axisYu Ren, Xuan Zhou, Juan-Juan Yang, et al.
Frontiers in Oncology|October 10, 2022
Plasma arginase-1 as a predictive marker for early transarterial chemoembolization refractoriness in unresectable hepatocellular carcinomaWei-Li Xia, Shi-Jun Xu, Yuan Guo, et al.
Molecular Cancer|January 13, 2018
Paracrine and epigenetic control of CAF-induced metastasis: the role of HOTAIR stimulated by TGF-ß1 secretionYu Ren, Huan-Huan Jia, Yi-Qi Xu, et al.
Frontiers in Oncology|October 24, 2022
Prospective study of TACE combined with sorafenib vs TACE combined with 125I seed implantation in the treatment of hepatocellular carcinoma with portal vein tumor thrombus and arterioportal fistulasXiao-Hui Zhao, Hang Yuan, Wei-Li Xia, et al.
Pageof 12